Literature DB >> 6945162

Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

C G Kallenberg, J M Van der Voort-Beelen, J D'Amaro, T H The.   

Abstract

Twenty-eight patients with scleroderma were typed for 40 HLA antigens. A highly significant increase in the frequency of HLA-B8 and HLA-DR3 was observed, which was not related to the severity of the disease. In vitro lymphocyte stimulation tests were performed in 26 patients. In addition, humoral and in vitro cellular immune responses to a primary test antigen were measured in 12 of them. Although the group of scleroderma patients as a whole had an impaired cellular response, only the B8/DR3+ patients had a strongly depressed response, whereas the immune response of the others was normal. These findings suggest an association of the haplotype B8/DR3 with impaired cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945162      PMCID: PMC1537173     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  ANTINUCLEAR AND PRECIPITATING AUTOANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS.

Authors:  J S BECK; J R ANDERSON; K G GRAY; N R ROWELL
Journal:  Lancet       Date:  1963-12-07       Impact factor: 79.321

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

Review 3.  Protein clinical manifestations of primary tumors of the heart.

Authors:  H O McDevitt; W F Bodmer
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

4.  HL-A antigens and acute lymphocytic leukemia: the nature of the HL-A2 association.

Authors:  G N Rogentine; R J Trapani; R A Yankee; E S Henderson
Journal:  Tissue Antigens       Date:  1973

5.  The human immune response to alpha-haemocyanin of Helix pomatia.

Authors:  G C de Gast; T H The; J A Snijder
Journal:  Acta Med Scand       Date:  1973-10

6.  Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder.

Authors:  S Currie; M Saunders; M Knowles
Journal:  Br J Dermatol       Date:  1971-05       Impact factor: 9.302

7.  Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

Authors:  T Sasazuki; Y Kohno; I Iwamoto; M Tanimura; S Naito
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

8.  Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors:  N F Rothfield; G P Rodnan
Journal:  Arthritis Rheum       Date:  1968-10

9.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

10.  Uracil-specific anti-R.N.A. antibodies in scleroderma.

Authors:  D Alarcón-Segovia; E Fishbein; E García-Ortigoza; S Estrada-Parra
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

View more
  24 in total

Review 1.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

Authors:  P J Maddison; R P Skinner; R S Pereira; C M Black; B M Ansell; M I Jayson; N R Rowell; K I Welsh
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

4.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1.

Authors:  S Hashimoto; J P Michalski; M A Berman; C McCombs
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

Review 5.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

6.  Limited cutaneous systemic sclerosis arising in a patient with Graves' disease.

Authors:  Marc Gregory Yu; John Paul Montinola Quisumbing
Journal:  BMJ Case Rep       Date:  2017-01-27

7.  Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.

Authors:  E Soppi; A Lehtonen; A Toivanen
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

8.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).

Authors:  C J Lynch; G Singh; T L Whiteside; G P Rodnan; T A Medsger; B S Rabin
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.